Clinical trial
Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study. A Sub-study of Implementation of HIV Pre-exposure Prophylaxis (PrEP) for Men Who Have Sex With Men and Transgender People: A Demonstration Project in the Context of Combined Prevention in Brazil, Mexico and Peru - the ImPrEP Study
NCT05674682 is registered in ClinicalTrials.gov with Evandro Chagas National Institute of Infectious Disease as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study. A Sub-study of Implementation of HIV Pre-exposure Prophylaxis (PrEP) for Men Who Have Sex With Men and Transgender People: A Demonstration Project in the Context of Combined Prevention in Brazil, Mexico and Peru - the ImPrEP Study
- Lead sponsor
- Evandro Chagas National Institute of Infectious Disease
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2019
- Completion date
- June 30, 2020
- Enrollment
- 4,000 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection primary, hiv infections, hiv seropositivity, risk behavior, risk reduction, risky health behavior, std